Nantong Bencao Quadriga Medical Technology Co. Ltd.

This study tests a new drug called NBQ72S in 10 breast cancer patients whose cancer has spread to the lining of the brain or spinal cord. Participants receive the drug every 28 days. The goal is to see if the drug can control the cancer and improve survival, but it is not expecte…